GlassScriptPhysician profile
Anne Wissman
NPI 1437757184
$8,170.03
in general payments reported to CMS, 2019-2025
50 companies · $1,355 in 2025
The $1,355 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,701 · 2022: $1,117 · 2023: $2,504 · 2024: $1,492 · 2025: $1,355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,677 · Travel and Lodging: $667 · Education: $8.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,677.08 |
| Travel and Lodging | $666.69 |
| Education | $8.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,008.99 | 2022-2025 | Relistor |
| Boston Scientific Corporation | $974.39 | 2022-2025 | Wavewriter Alpha Prime 16 |
| Abbvie INC. | $867.14 | 2021-2025 | |
| Medtronic, INC. | $663.03 | 2022-2025 | Intellis Adaptivestim, Inceptiv |
| Curonix LLC | $597.00 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Scilex Pharmaceuticals INC. | $445.89 | 2022-2025 | Ztlido |
| Collegium Pharmaceutical, INC. | $310.37 | 2023-2024 | Xtampza, Belbuca |
| Abbott Laboratories | $236.94 | 2023-2025 | Proclaim, Eterna |
| Grt US Holding, INC. | $236.93 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $231.21 | 2022 | |
| Nalu Medical, INC. | $230.93 | 2024-2025 | Nalu Neurostimulation System |
| Teva Pharmaceuticals USA, INC. | $183.44 | 2021 | |
| Jazz Pharmaceuticals INC. | $151.01 | 2021 | |
| Nevro Corp. | $148.84 | 2022-2024 | Senza |
| Lilly USA, LLC | $145.48 | 2021-2024 | Emgality, Reyvow |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Wissman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.